Showing information for "2,4-dimethylheptane"


Metabolite information

HMDB ID -
Synonyms
-
Chemical formula -
IUPAC name
-
CAS registry number -
Monoisotopic molecular weight -

Chemical taxonomy

Super class -
Class -
Sub class -

Biological properties

Pathways
-

The studies that identify "2,4-dimethylheptane" as a lung cancer-related metabolite

The studies that identify "2,4-dimethylheptane" as a lung cancer-related metabolite


Reference Country Specimen Marker function Participants (Case) Participants (Control)
Cancer type Stage Number Gender (M,F) Age mean (range) (M/F) Smoking status Type Number Gender (M,F) Age mean (range) (M/F) Smoking status
Filipiak et al. 2014 Austria tissue diagnosis NSCLC, SCLC I, II, III, IV 14 6, 8 67.7, 63.4 smoker, non-smoker tumor vs. adjacent normal tissue 13 12, 16 52 ± 17 former, non-smokers
Filipiak et al. 2014 Austria exhaled breath diagnosis SCLC, squamous cell carcinoma, adenocarcinoma, large cell carcinoma, mesothelioma, carcinoid – 36 25, 11 63 ± 7 former, non-smokers healthy 28 12, 16 52 ± 17 former, non-smokers
Reference Chromatography Ion source Positive/Negative mode Mass analyzer Identification level
Filipiak et al. 2014 GC – – – –
Filipiak et al. 2014 GC – – – –
Reference Data processing software Database search
Filipiak et al. 2014 – NIST 2005
Filipiak et al. 2014 – NIST 2005
Reference Difference method Mean concentration (case) Mean concentration (control) Fold change (case/control) P-value FDR VIP
Filipiak et al. 2014 Kruskal–Wallis test, Spearman – – – – – –
Filipiak et al. 2014 Kruskal–Wallis test, Spearman – – – – – –
Reference Classification method Cutoff value AUROC 95%CI Sensitivity (%) Specificity (%) Accuracy (%)
Filipiak et al. 2014 Kruskal–Wallis test, Spearman – – – – –
Filipiak et al. 2014 Kruskal–Wallis test, Spearman – – – – –